James Noble
2015
In 2015, James Noble earned a total compensation of $761.4K as Chief Executive Officer at Adaptimmune Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $294,720 |
|---|---|
| Salary | $442,080 |
| Other | $24,621 |
| Total | $761,421 |
Noble received $442.1K in salary, accounting for 58% of the total pay in 2015.
Noble also received $294.7K in non-equity incentive plan and $24.6K in other compensation.
Rankings
In 2015, James Noble's compensation ranked 9,185th out of 13,638 executives tracked by ExecPay. In other words, Noble earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,185 out of 13,638 | 33rd |
Division Manufacturing | 3,497 out of 5,190 | 33rd |
Major group Chemicals And Allied Products | 1,280 out of 1,854 | 31st |
Industry group Drugs | 1,041 out of 1,528 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 181 out of 254 | 29th |
Source: SEC filing on April 28, 2017.
Noble's colleagues
We found two more compensation records of executives who worked with James Noble at Adaptimmune Therapeutics in 2015.